-
Trump’s Cuts Impact Low-Income Children’s Care
President Trump signed significant legislation reducing safety-net programs, marking the largest cut in U.S. history. This move is expected to leave nearly 12 million Americans without health insurance. The cuts target programs that support low-income children, raising concerns about the future of healthcare access for vulnerable populations. Critics argue that these changes could exacerbate existing…
-
Humana Loses Medicare Bonus Lawsuit
Humana Inc. experienced a drop in its stock value following a court decision against its lawsuit to overturn cuts to its Medicare bonus payments. The insurer had aimed to recover billions in revenue through this legal action. The court’s ruling represents a significant financial setback for Humana, which relied on these bonuses as a substantial…
-
Medicaid Data Shared with ICE Sparks Outcry
The Trump administration has authorized Immigration and Customs Enforcement (ICE) to access personal data of 79 million Medicaid enrollees. This includes sensitive information like addresses and ethnicities, aimed at identifying immigrants living illegally in the U.S. The agreement between the Centers for Medicare and Medicaid Services (CMS) and the Department of Homeland Security has not…
-
FDA Raises Concerns on GSK Drug Safety
The FDA has raised safety concerns about GSK’s new drug for multiple myeloma. The agency’s questions focus on potential side effects that could impact patient safety. GSK must address these issues to move forward with the drug’s approval process. This development could delay the drug’s market entry, affecting GSK’s strategy and financial projections. The scrutiny…
-
Senator Criticizes Kennedy’s Vaccine Decisions
Senator Lisa Blunt Rochester criticizes Health and Human Services Secretary Robert F. Kennedy for his recent actions regarding vaccine policy. Kennedy, known for his vaccine skepticism, dismissed the Advisory Committee on Immunization Practices (ACIP) and replaced its members with individuals lacking relevant expertise. This move has raised concerns about public health safety and trust in…
-
U.S. Policies Strain Life Sciences Startups
A prominent biotech investor warns that current U.S. policies are creating challenges for life sciences startups. Johannes Fruehauf, a partner at VC firm Mission BioCatpial, says that these policies are leading to increased operational costs and regulatory hurdles. The investor predicts further disruptions in the sector if these issues are not addressed. Startups face difficulties…
